The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...

GSK plc announced the acquisition of ordinary shares by several key executives under the Company’s Share Reward Plan. This transaction, conducted on the London Stock Exchange, involved the purchase of ...

Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK plc has announced the purchase of 494,426 of its own ordinary shares as part of ...

Cambridge based drug sleuth Bicycle Therapeutics has extended its cash runway from mid-2027 into 2028 as it closes in on ...

GlaxoSmithKline Pharmaceuticals' shares fell by 2% in Thursday's morning trade, reflecting a bearish market sentiment. The company is currently trading at Rs 2,680.10 per share.

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline today and set a price target of £13.97. The company’s shares opened today at p1,424.50. Take advantage of TipRanks Premium ...

In a report released today, Steve Scala from TD Cowen maintained a Hold rating on GlaxoSmithKline. The company’s shares closed yesterday at $37.67. Take advantage of TipRanks Premium at 50% off!

GlaxoSmithKline Pharmaceuticals Q1 net profit rises 12% to Rs 279 crore, despite slight dip in total income. Company highlights upcoming oncology drug launches.

Delhi Police have busted a medicine racket making counterfeit life-saving drugs using the names of big pharma companies such ...

Pfizer is the closest company to producing a Lyme disease vaccine. Experts are concerned that vaccine skepticism could stand in its way.

British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...